Global AI in Medical Diagnostics Market Poised for Phenomenal Expansion at a CAGR of ~22% by 2032 | DelveInsight

By GlobeNewswire On Oct 28, 2025

The global artificial intelligence in medical diagnostics market is expanding rapidly, fueled by the growing incidence of chronic, genetic, and infectious diseases. AI solutions enable early detection, accurate diagnosis, and tailored treatment by processing complex medical data and uncovering subtle patterns. This expansion is further supported by heightened research and development efforts, strategic partnerships, and ongoing product innovations by leading market players, which are driving faster clinical adoption across healthcare environments.

New York, USA, Oct. 28, 2025 (GLOBE NEWSWIRE) — Global AI in Medical Diagnostics Market Poised for Phenomenal Expansion at a CAGR of ~22% by 2032 | DelveInsight

DelveInsight’s AI in Medical Diagnostics Market Insights report provides the current and forecast market analysis, individual leading AI in medical diagnostics companies’ market shares, challenges, AI in medical diagnostics market drivers, barriers, trends, and key AI in medical diagnostics companies in the market.

AI in Medical Diagnostics Market Summary

The global AI in medical diagnostics market size is expected to increase from USD 1.6 billion in 2024 to ~USD 8 billion by 2032, reflecting strong and sustained growth.
The global AI in medical diagnostics market is expected to grow at a CAGR of ~22% during the forecast period from 2025 to 2032.
The leading companies working in the AI in medical diagnostics market include GE HealthCare, Aidoc, Qure.ai, Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Tecomet Inc., Prenosis, Inc., Riverain Technologies, Envisionit Deep AI (Pty) Ltd., Deep Bio Inc., and others.
Among all the regions, North America is anticipated to register the fastest growth in the AI in medical diagnostics market during the forecast period.
In 2024, the hardware/software category held the largest market share in the component segment of artificial intelligence in medical diagnostics.

To read more about the latest highlights related to the AI in medical diagnostics market, get a snapshot of the key highlights entailed in the Global AI in Medical Diagnostics Market Forecast Report

Key Factors Contributing to the Rise in Growth of the AI in Medical Diagnostics Market

Increasing Burden of Chronic and Lifestyle Diseases

Rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and lifestyle-related conditions is driving demand for faster, more accurate diagnostics, where AI can play a crucial role.

Advances in AI and Machine Learning Technologies

Continuous improvements in AI algorithms, deep learning, and neural networks enhance the accuracy and efficiency of diagnostics, enabling better image analysis, pattern recognition, and predictive analytics.

Growing Adoption of Digital Health Tools

The integration of AI with electronic health records (EHRs), telemedicine platforms, and wearable devices enables seamless data collection and analysis, supporting AI-driven diagnostic solutions.

Rising Investment and R&D in Healthcare AI

Significant funding from private investors, government initiatives, and healthcare organizations is accelerating the development and commercialization of AI-powered diagnostic tools.

Increasing Demand for Early and Precise Diagnosis

AI enables early detection of diseases, which improves patient outcomes and reduces healthcare costs, creating strong demand from hospitals, clinics, and diagnostic centers.

Shortage of Skilled Healthcare Professionals

AI-powered diagnostics help bridge the gap created by the shortage of radiologists, pathologists, and other specialists, offering automated and rapid diagnostic support.

Regulatory Approvals and Government Initiatives

Supportive regulations and initiatives promoting AI adoption in healthcare are facilitating market growth globally.

Cost-Effectiveness and Operational Efficiency

AI reduces diagnostic errors, speeds up workflows, and optimizes resource utilization, making it an attractive solution for healthcare providers.

Get a sneak peek at the AI in medical diagnostics market dynamics @ AI in Medical Diagnostics Market Trends

Regional AI in Medical Diagnostics Market Insights

In 2024, North America, led by the U.S., dominated the global artificial intelligence in medical diagnostics market with a 51% share. The region’s market is witnessing strong growth due to the rising prevalence of chronic diseases such as cancer, lifestyle-related conditions like diabetes, and infectious diseases, including HIV. This increasing disease burden, coupled with a robust healthcare infrastructure, advanced R&D in AI-based diagnostics, and fast regulatory approvals, establishes the U.S. as a global leader in AI-powered diagnostic innovations.

Europe’s artificial intelligence in medical diagnostics market is growing steadily, supported by technological advancements in AI, expanding healthcare digitization, and strong regulatory and policy frameworks. AI adoption in medical imaging, pathology, cardiology, and oncology enhances diagnostic accuracy, operational efficiency, and patient care outcomes. Investments in smart hospitals, integrated healthcare IT systems, and AI-enabled diagnostic platforms enable broader implementation. At the same time, government initiatives, funding programs, and clear regulatory pathways encourage widespread AI integration in healthcare.

The Asia-Pacific AI in medical diagnostics market is also experiencing significant growth, driven by rapid technological progress, increasing healthcare demand, and proactive government support. AI technologies such as machine learning and deep learning are enhancing the speed, accuracy, and efficiency, particularly in medical imaging, pathology, and predictive diagnostics. Expanding healthcare infrastructure is facilitating the broader deployment of AI diagnostic tools, helping address chronic disease burdens and the challenges an aging population poses. Government incentives and policies are further supporting AI adoption, promoting R&D, and enabling healthcare providers to implement innovative diagnostic solutions.

To know more about why North America is leading the market growth in the AI in medical diagnostics market, get a snapshot of the AI in Medical Diagnostics Market Share

Recent Developmental Activities in the AI in Medical Diagnostics Market

In April 2025, Roche announced that the U.S. Food and Drug Administration (FDA) had granted Breakthrough Device Designation to its VENTANA® TROP2 (EPR20043) RxDx Device. This represents the first time a computational pathology companion diagnostic (CDx) device has received a Breakthrough Device Designation.
In April 2025, Avant Technologies, Inc. and its joint venture partner Ainnova Tech, Inc. announced that the U.S. Food and Drug Administration (FDA) is reviewing its pre-submission package for a meeting concerning Avant’s VisionAI platform. The technology is designed to transform early disease detection through artificial intelligence.
In April 2025, Proprio announced that its Paradigm AI surgical guidance platform had received FDA 510(k) clearance to incorporate intraoperative measurements. This allows the first-ever real-time 3D, dynamic, and segmental visualization and measurement of anatomy during surgery.

What is AI in Medical Diagnostics?

Artificial Intelligence is transforming medical diagnostics by enabling faster, more accurate, and personalized detection of diseases. Machine learning algorithms and deep learning models can analyze vast amounts of medical data, such as imaging scans, lab results, and genetic information—far more quickly than human clinicians. For instance, AI-powered imaging tools can detect early signs of cancers, cardiovascular conditions, and neurological disorders with remarkable precision, often identifying patterns that the human eye may miss. By automating routine analyses, AI reduces diagnostic errors and allows healthcare professionals to focus on complex decision-making and patient care.

AI in Medical Diagnostics Market Report Metrics	Details
Coverage	Global
Study Period	2022–2032
AI in Medical Diagnostics Market CAGR	~22%
AI in Medical Diagnostics Market Size by 2032	~USD 8 Billion
Key AI in Medical Diagnostics Companies	GE HealthCare, Aidoc, Qure.ai, Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Tecomet Inc., Prenosis, Inc., Riverain Technologies, Envisionit Deep AI (Pty) Ltd., Deep Bio, Inc., and others

AI in Medical Diagnostics Market Assessment

AI in Medical Diagnostics Market Segmentation
- AI in Medical Diagnostics Market Segmentation By Component: Hardware/Software and Services
- AI in Medical Diagnostics Market Segmentation By Application: Infectious Disease Diagnostics, Radiology, Oncology, Cardiology, and Others
- AI in Medical Diagnostics Market Segmentation By Technology: Machine Learning, Natural Language Processing, and Others
- AI in Medical Diagnostics Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the AI in medical diagnostics market are set to emerge as the trendsetter explore @ AI in Medical Diagnostics Market Analysis

Table of Contents

1	AI in Medical Diagnostics Market Report Introduction
2	AI in Medical Diagnostics Market Executive Summary
3	Competitive Landscape
4	Regulatory Analysis
5	AI in Medical Diagnostics Market Key Factors Analysis
6	AI in Medical Diagnostics Market Porter’s Five Forces Analysis
7	AI in Medical Diagnostics Market Layout
8	AI in Medical Diagnostics Market Company and Product Profiles
9	KOL Views
10	Project Approach
11	About DelveInsight
12	Disclaimer & Contact Us

Interested in knowing the AI in medical diagnostics market share by 2032? Click to get a snapshot of the AI in Medical Diagnostics Market Size

Related Reports

AI in Diagnostics Market

AI in Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in diagnostics companies, including Aidoc, Owkin, Inc., Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Terarecon, Inc., Prenosis, Inc., Ibex, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, Terarecon, Inc., Aiforia, RADLogics, among others.

AI in Cancer Diagnostics Market

AI in Cancer Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in cancer diagnostics companies, including iCAD, Inc., ibex-ai, Roche Diagnostics, Kheiron Medical Technologies Limited, MVision AI Inc., Siemens Healthineers AG, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., IBM Corporation, Azra AI, ConcertAI, PathAI, Median Technologies, Paige AI Inc., Therapixel, Flatiron, Freenome Holdings Inc., Onc.AI, Sonrai Analytics, among others.

Artificial Intelligence In Clinical Trials Market

Artificial Intelligence In Clinical Trials Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in clinical trials companies, including TEMPUS, NetraMark, ConcertAI, AiCure, Medpace, Inc., ICON plc, Charles River Laboratories, Dassault Systèmes, Oracle, Certara, Cytel Inc., Phesi, DeepHealth, Unlearn.ai, Inc., H1, TrialX, Suvoda LLC, Risklick, Lokavant, Research Solutions, among others.

Artificial Intelligence In Drug Discovery Market

Artificial Intelligence in Drug Discovery Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in drug discovery companies, including IBM Corporation, Numedii Inc, Deep Genomics, NVIDIA Corporation, Atomwise Inc, Cloud Pharmaceuticals Inc, Alphabet Inc (DeepMind), Insilico Medicine, BenevolentAI, Exscientia, Cyclia, Valo Health, Owkin Inc, Verge Genomics, BioSymetrics, among others.

Artificial Intelligence in Precision Medicine Market

Artificial Intelligence in Precision Medicine Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in precision medicine companies, including TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., among others.

DelveInsight’s Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.

Other Business Pharmaceutical Consulting Services

Healthcare Conference Coverage

Pipeline Assessment

Healthcare Licensing Services

Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

CONTACT: Contact Us Shruti Thakur  [email protected]  +14699457679

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. NewIndiaObserver.com takes no editorial responsibility for the same.